Latest news
Loading news…
AcroImmune is a biotechnology company that develops immunotherapy drugs to treat malignant tumors and inflammatory diseases.
AcroImmune was acquired by OncoC4 in 2024.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Guangzhou, Guangdong, China
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to AcroImmune
Loading news…
FAQs about AcroImmune
People who checked this page also checked these
Browse the full Acquirezy directory.